Medtronic PLC MDT

88.64 0.13 0.15% as of 25 Sep
Market cap
$112.2B
P/E
21.7×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

Medtronic PLC (MDT) Free cash flow margin

Medtronic PLC's free cash flow margin over the twelve months to 31 July 2026 was 16.3%, up 1.4 percentage points from fiscal 2026 (14.9%). Over the past ten years it has ranged from 12.1% (fiscal 2018) to 21.4% (fiscal 2015); the current reading is higher than 33% of that period. That is above the Medical Devices industry median of −7.24% and above the Healthcare sector median of 0.00%.

Free cash flow margin, annual

Annual

Period Free cash flow margin Change (points)
FY2026 14.9% (0.54)
FY2025 15.5% (0.61)
FY2024 16.1% 1.40
FY2023 14.7% (4.20)
FY2022 18.9% 2.65
FY2021 16.2% (4.60)
FY2020 20.8% 1.60
FY2019 19.2% 7.15
FY2018 12.1% (6.87)
FY2017 18.9% 4.47

Against its own ten years

Low 12.1% High 21.4%
Ten-year median 16.1%
Current reading's percentile 33

Free cash flow margin against peers

Company Free cash flow margin
DXCM DexCom, Inc. compare 28.3%
EW Edwards Lifesciences Corporation compare 22.0%
SYK Stryker Corporation compare 18.2%
BSX Boston Scientific Corporation compare 17.3%
ABT Abbott Laboratories compare 16.8%
MDT Medtronic PLC 16.3%
STE STERIS plc compare 15.5%
PHG Koninklijke Philips N.V. compare 8.99%
GEHC GE HealthCare Technologies Inc. compare 7.42%
Medical Devices industry median −7.24%
Healthcare sector median 0.00%
Market median 0.00%

What Free cash flow margin is

Free Cash Flow Margin tells an investor how much of each sale turns into cash the company keeps after paying for investment in its assets.

(Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)) ÷ Revenue

The full definition of Free cash flow margin →

More on MDT